课题基金 / 基金详情

Modulation of The Serotonin System as a Novel Therapeutic Strategy in of Autism Spectrum Disorder

Modulation of The Serotonin System as a Novel Therapeutic Strategy in of Autism Spectrum Disorder
调节血清素系统作为自闭症谱系障碍的新型治疗策略
批准号：
440589
负责人：
Inserra Antonio
金额：
$9.83万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-12-01 至 2023-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=440589&lang=en
关键词：
Autism Spectrum Disorder Behavioural Pharmacology Electrophysiology Lysergic Acid Diethylamide Molecular Pharmacology Prefrontal Cortex Serotonin Serotonin 2a Receptor Agonism Thalamus Translational Study

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Autism spectrum disorder (ASD) is characterized by impairments in social behavior and emotional processing. To date, no therapies exist that specifically target ASD. ASD patients have altered activity in brain areas implicated in social behaviour, and em
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金